- Start
- Nov 21, 202590% CONFIDENCEfrom the source
Eli Lilly Becomes the First Drugmaker Worth $1 Trillion
- On Friday 21 November 2025 Eli Lilly became the first drugmaker to reach $1 trillion in market value, and the second US non-technology company after Berkshire Hathaway to do so.[1][3]
- Shares hit a record intraday high of $1,066.65 and closed at $1,059.70, up from $1,043.29 the day before.[4]
- On the 945,383,757 shares Lilly reported outstanding on 27 October 2025, that close is worth about $1.002 trillion, so Lilly finished the day above the mark; the previous day's high of $1,057.00 had fallen just short.[4][5]
- The stock had risen more than 35% in 2025 and traded at about 50 times expected earnings, on demand for tirzepatide (Mounjaro and Zepbound), which overtook Keytruda as the world's best-selling drug.[2]
- Mounjaro brought in $6.52 billion and Zepbound $3.59 billion in the third quarter of 2025, up 109% and 184%, while rival Novo Nordisk's shares had fallen nearly 45% that year.[3]
- At $1 trillion Lilly was worth two thirds of Meta, more than Walmart, and more than twice Johnson & Johnson, its closest pharma peer.[1]
References 587% CONFIDENCE
The first entry is always the pin's source. Overall confidence is a weighted average of how firmly each reference supports the start and end times used above; a reference counts half as much for every 180 days older than the newest.
- [1]90%biopharmadive.com/news/eli-lilly-1-trillion-pharmaceutical-market-value-obesity/721819biopharmadive.com· Posted Sep 23, 2026· Starts Nov 21, 2025 ✓· 45% of score
BioPharma Dive (published Nov. 21, 2025): Lilly "on Friday briefly became the first drugmaker to reach $1 trillion in market value"; Reuters the same day: "Eli Lilly hit $1 trillion in market value on Friday". Nasdaq's[4] daily prices show the 21 Nov close of $1,059.70 x 945,383,757 shares (10-Q cover) = $1.0018 trillion, and the 20 Nov high of $1,057.00 below the mark, so 21 Nov is the first day both intraday and at the close.
- [2]90%Lilly becomes first drugmaker to hit $1 trillion valuation on weight-loss demand (Reuters)finance.yahoo.com· Published Nov 21, 2025· 14% of score
Reuters report the same day: Lilly hit $1 trillion in market value on Friday, shares briefly at a record and trading near $1,051; 35% rally, 50x forward earnings, tirzepatide outselling Keytruda.[1]
- [3]85%Eli Lilly hits $1 trillion market value, a first in health care, as Novo Nordisk tumblescnbc.com· Published Nov 21, 2025· 14% of score
CNBC on the milestone: first health-care company to reach $1 trillion, second US non-tech company after Berkshire Hathaway; Q3 2025 Mounjaro and Zepbound sales; Novo Nordisk down nearly 45% in 2025.
- [4]80%LLY historical daily prices (Nasdaq)api.nasdaq.com· Published Nov 21, 2025· 14% of score
Nasdaq's daily quotes: 21 Nov 2025 high $1,066.65, close $1,059.70; 20 Nov close $1,043.29, high $1,057.00 - the day the $1 trillion mark (about $1,057.79 a share) was first reached and held at the close.
- [5]80%Eli Lilly Form 10-Q for the quarter ended September 30, 2025 (SEC EDGAR)sec.gov· Published Oct 30, 2025· 13% of score
Cover page: 945,383,757 shares of common stock outstanding as of October 27, 2025 - the share count that turns the 21 Nov close into a market value above $1 trillion.[1]
Suggest a correction
Something missing or wrong? Say it in your own words: a link that backs this pin up, a different start or end date and why, or a fact it lacks or gets wrong. The AI checks it against this pin's sources, searches for better ones, and adds any page that backs you up. The pin's own sources still count most.
